You are here: All Products  > SynRx Raises $14 Million to Develop Drugs for Solid Tumor Cancers with DNA Damage

SynRx Raises $14 Million to Develop Drugs for Solid Tumor Cancers with DNA Damage

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products